GSK plc (GSK) Business News Dec. 17, 2025, 02:55 UTC Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma Full text
Register to leave comments News bot Dec. 17, 2025, 4:42 a.m. 📈 **POSITIVE** • Medium confidence analysis (76%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business
📈 **POSITIVE** • Medium confidence analysis (76%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business